drugset / Trial / NCT01513668

A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fed Condition

NCT01513668

Completed 40 enrolled Ranbaxy Laboratories Limited
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to compare single-dose oral bioavailability of acetaminophen 650 mg extended release geltabs (containing acetaminophen 650 mg) of OHM Laboratories, USA (subsidiary of Ranbaxy) with Tylenol extended release geltabs (containing acetaminophen 650 mg) of Mc Neil, Consumer \& Specialty Pharmaceuticals, U.S.A in healthy, adult, male human subjects under fed condition.

Timeline

Start
2006-05
Primary completion
2006-05
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 650 mg Oral

Indications

No indication recorded.